Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

[Value of serum advanced glycation end products-peptide in the screening of diabetes mellitus in a community-based population of high-risk diabetics].

Xie ZL, Zhang L, Wang YP, He JJ, Zhou Y, Lei CH, Qiu SH, Sun ZL.

Zhonghua Yi Xue Za Zhi. 2012 Oct 30;92(40):2843-6. Chinese.

PMID:
23290214
2.

Serum 1,5-anhydroglucitol level as a screening tool for diabetes mellitus in a community-based population at high risk of diabetes.

Wang Y, Yuan Y, Zhang Y, Lei C, Zhou Y, He J, Sun Z.

Acta Diabetol. 2017 May;54(5):425-431. doi: 10.1007/s00592-016-0944-z. Epub 2016 Nov 28.

PMID:
27896445
3.

The diagnostic threshold of HbA1c and impact of its use on diabetes prevalence-a population-based survey of 6898 Han participants from southern China.

Huang H, Peng G, Lin M, Zhang K, Wang Y, Yang Y, Zuo Z, Chen R, Wang J.

Prev Med. 2013 Oct;57(4):345-50. doi: 10.1016/j.ypmed.2013.06.012. Epub 2013 Jun 15.

PMID:
23777673
4.

Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.

Hu Y, Liu W, Chen Y, Zhang M, Wang L, Zhou H, Wu P, Teng X, Dong Y, Zhou Jw, Xu H, Zheng J, Li S, Tao T, Hu Y, Jia Y.

Acta Diabetol. 2010 Sep;47(3):231-6. doi: 10.1007/s00592-009-0143-2. Epub 2009 Sep 17.

PMID:
19760291
5.

Using Serum Advanced Glycation End Products-Peptides to Improve the Efficacy of World Health Organization Fasting Plasma Glucose Criterion in Screening for Diabetes in High-Risk Chinese Subjects.

Sun Z, He J, Qiu S, Lei C, Zhou Y, Xie Z, Zhang L, Wang Y, Jin H.

PLoS One. 2015 Sep 14;10(9):e0137756. doi: 10.1371/journal.pone.0137756. eCollection 2015.

6.

Diagnostic efficiency of hemoglobin A1c for newly diagnosed diabetes and prediabetes in community-based Chinese adults aged 40 years or older.

Liang K, Sun Y, Li WJ, Zhang XP, Li CQ, Yang WF, Ma ZQ, Ma AX, Zheng HZ, Song J, Lin P, Hou XG, Chen L.

Diabetes Technol Ther. 2014 Dec;16(12):853-7. doi: 10.1089/dia.2014.0157. Epub 2014 Jul 11.

7.

Fasting cut-offs in determining the prevalence of diabetes and intermediate glucose abnormality in a non-obese population.

Sayeed MA, Mahtab H, Khanam PA, Keramat Ali SM, Chowdhury RI, Vaaler S, Hussain A, Azad Khan AK.

Bangladesh Med Res Counc Bull. 2004 Dec;30(3):105-14.

PMID:
16240981
8.

A Comparison of hs-CRP Levels in New Diabetes Groups Diagnosed Based on FPG, 2-hPG, or HbA1c Criteria.

Tutuncu Y, Satman I, Celik S, Dinccag N, Karsidag K, Telci A, Genc S, Issever H, Tuomilehto J, Omer B.

J Diabetes Res. 2016;2016:5827041. doi: 10.1155/2016/5827041. Epub 2015 Dec 28.

9.

Can HbA1c replace OGTT for the diagnosis of diabetes mellitus among Chinese patients with impaired fasting glucose?

Yu EY, Wong CK, Ho SY, Wong SY, Lam CL.

Fam Pract. 2015 Dec;32(6):631-8. doi: 10.1093/fampra/cmv077. Epub 2015 Oct 14.

PMID:
26467644
10.

[Study of glycated albumin cut-off point in diabetes mellitus and impaired glucose regulation].

Zhang T, He H, Yang HL, Huang HJ, Zhang MF, An ZM, Li SQ.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 Mar;45(2):274-7, 298. Chinese.

PMID:
24749356
11.
12.

[Combined utility of hemoglobin A1c and glycated albumin in diabetic screening].

Li Q, Pan JM, Ma XJ, Bao YQ, Tang JL, Yuan QY, Lu HJ, Jia WP.

Zhonghua Yi Xue Za Zhi. 2011 Jul 12;91(26):1813-6. Chinese.

PMID:
22093780
13.

Glycated haemoglobin in diagnosis of diabetes mellitus and pre-diabetes among middle-aged and elderly population: Shanghai Changfeng study.

Ma H, Gao X, Lin HD, Hu Y, Li XM, Gao J, Zhao NQ.

Biomed Environ Sci. 2013 Mar;26(3):155-62. doi: 10.3967/0895-3988.2013.03.001.

14.

Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.

Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, So WY, Wai HP, Cockram CS.

Diabetes Care. 1998 Aug;21(8):1221-5.

PMID:
9702423
15.

HbA1c and the diagnosis of diabetes and prediabetes in a middle-aged and elderly Han population from northwest China (HbA1c).

Wu S, Yi F, Zhou C, Zhang M, Zhu Y, Tuniyazi Y, Huang L, Huang X, Wang F, Bi Y, Ning G.

J Diabetes. 2013 Sep;5(3):282-90. doi: 10.1111/1753-0407.12035. Epub 2013 May 28.

PMID:
23452328
16.

The value of HbA1c for diagnosing type 2 diabetes mellitus between Chinese Uyghurs and Hans in Xinjiang.

Li SY, Wang SY, Li J, Sun K, Zhang Z, Cao GL.

Int J Clin Exp Med. 2015 Jul 15;8(7):11352-5. eCollection 2015.

17.

The cutoffs and performance of glycated hemoglobin for diagnosing diabetes and prediabetes in a young and middle-aged population and in an elderly population.

Yan ST, Xiao HY, Tian H, Li CL, Fang FS, Li XY, Cheng XL, Li N, Miao XY, Yang Y, Wang LC, Zou XM, Ma FL, He Y, Sai XY.

Diabetes Res Clin Pract. 2015 Aug;109(2):238-45. doi: 10.1016/j.diabres.2015.05.047. Epub 2015 Jun 1.

PMID:
26059072
18.

The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors.

Ko GT, Chan JC, Woo J, Lau E, Yeung VT, Chow CC, Cockram CS.

Ann Clin Biochem. 1998 Jan;35 ( Pt 1):62-7.

PMID:
9463740
19.

Prevalence of diabetes mellitus in the elderly of Namwon County, South Korea.

Kim SG, Yang SW, Jang AS, Seo JP, Han SW, Yeom CH, Kim YC, Oh SH, Kim JS, Nam HS, Chung DJ, Chung MY.

Korean J Intern Med. 2002 Sep;17(3):180-90.

20.

Ideal glycated hemoglobin cut-off points for screening diabetes and prediabetes in a Chinese population.

Liu Y, Xiao X, Sun C, Tian S, Sun Z, Gao Y, Li Y, Cheng J, Lv Y, Li M, Li Z, Zhang Y, Wang G, Liu Y, Gao Y, Zhu L, Liu Y, Wang G.

J Diabetes Investig. 2016 Sep;7(5):695-702. doi: 10.1111/jdi.12498. Epub 2016 May 3.

Supplemental Content

Support Center